Head-to-head comparison
The Edit vs Zealthy
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
The Edit names its pharmacy with an address and its prescriber with an NPI you can check, and prints its first-month rates larger than the standing prices they precede.
From $259/mo sema · From $349/mo tirz · Verified September 2026
Marked down on: The $200 and $300 first-order rates are printed larger than the standing $259 and $349, with no end date on the offer.
Desk Score
Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.
From $286/mo (lowest dose rung) sema · From $351/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.
The Edit takes this head-to-head with the higher Desk Score, 79/100 (C+) against 51/100 (C) for Zealthy. Zealthy still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
The Edit
79/100
C+
Zealthy
51/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | The Edit | Zealthy |
|---|---|---|
| Semaglutide | From $259/moFrom $259/mo (compounded) | From $286/molowest dose rung$286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | From $349/moFrom $349/mo (compounded) | From $351/molowest dose rung$351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | All 50 states claimed, no list published | 34 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Anyone who wants a checkable prescriber and a named pharmacy, and will budget on month two. | Not currently recommended — listed for transparency and reader awareness only. |
| Desk Score | 79/100C+ | 51/100C |
The verdict
Desk pick — The EditThe Edit takes this head-to-head with the higher Desk Score, 79/100 (C+) against 51/100 (C) for Zealthy. Zealthy still holds its ground where its strengths line up with yours.
Choose The Edit if…
Anyone who wants a checkable prescriber and a named pharmacy, and will budget on month two.
From $259/mo sema · From $349/mo tirz · All 50 states claimed, no list published
Choose Zealthy if…
Not currently recommended — listed for transparency and reader awareness only.
From $286/mo (lowest dose rung) sema · From $351/mo (lowest dose rung) tirz · 34 states
FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: The Edit · Zealthy.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs The Edit
- CoreAge Rx vs Zealthy
- Enhance MD vs The Edit
- Tryozi vs Zealthy
- Peak Wellness vs The Edit
- Aspen vs Zealthy
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.